BN Business News
Add your company to Business Communicator →

Regulation & law · 21/05/2012Updated: 10/17/2026 · 1 min read

Cedarburg Pharmaceuticals, Inc. Files Notice of Registration with the U.S. Drug Enforcement Administration for Controlled Substance Manufacturing

Summary

Cedarburg Pharmaceuticals, Inc. has submitted a notice of registration to the U.S. Drug Enforcement Administration (DEA) for its controlled substance manufacturing operations, as required by federal law.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →